Zevra Therapeutics, Inc 10-K for FY2023
Zevra Therapeutics, Inc. (ZVRA)
10-K
2024-04-01
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 10-K
Zevra Therapeutics, Inc filed this 10-K on April 1, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $27.46M
- up 170.3% from $10.16M a year earlier
- Net loss
- $46.05M
- compared with a net loss of $26.77M a year earlier